Atlantic Private Wealth’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.52K Hold
136
0.01% 185
2026
Q1
$6.91K Hold
136
﹤0.01% 199
2025
Q4
$4.01K Hold
136
﹤0.01% 214
2025
Q3
$3.51K Hold
136
﹤0.01% 207
2025
Q2
$3.75K Hold
136
﹤0.01% 201
2025
Q1
$3.86K Hold
136
﹤0.01% 194
2024
Q4
$5.66K Hold
136
﹤0.01% 176
2024
Q3
$9.09K Buy
+136
New +$12.5K 0.01% 153

Other funds holding MRNA

Atlantic Private Wealth's MRNA Position: Q2 2026 in Review

Atlantic Private Wealth held its Moderna (MRNA) position steady in Q2 2026 at 136 shares worth $9.52K. The position accounts for 0.01% of the portfolio, ranked #185.

Atlantic Private Wealth first reported a position in MRNA in Q3 2024 and has held it in 8 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Atlantic Private Wealth held 136 shares of Moderna worth $9.52K as of Q2 2026.
  • Atlantic Private Wealth left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of Atlantic Private Wealth's portfolio in Q2 2026, its #185 holding.
  • Atlantic Private Wealth first reported a position in Moderna in Q3 2024 and has held it in 8 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Atlantic Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.